$110m mkt cap, a$45m in cash and 3.1m ounces, page-32

One thing for sure; at this price either punters are short selling or else if not they are almost certain to be selling for a loss, and for many holders that could be a hefty one. We're now only a few cents above MET, who put out more decent assay results today but are still to calculate an intial resource estimate. Thus, in my view either MET are grossly overpriced or AMX is grossly underpriced. Obviously some positive news flow would help. I still think things will look a whole lot better in three months time.